The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

More information: Omer S. Ashruf et al, Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.0802 ...

MONDAY, March 10, 2025 (HealthDay News) -- For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic ...

Research letter: Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists. Image Credit: ALIOUI MA / Shutterstock In a recent study published in the journal JAMA ...

Patients with hematologic cancers such as leukemia who are hospitalized with COVID-19 are more likely to die than are those with solid cancers who contract the infection and go to the hospital, ...

Blood cancer, also known as hematologic cancer ... can be a sign of lymphoma, one of the types of blood cancer. READ ALSO: ...

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...

With Gleevec, a remarkable cancer drug, the approach was to target ... oncologist Brian Druker and his colleagues reported that "[c]omplete hematologic responses were observed in 53 of 54 patients ...